Big Pharma strikes back with data secrecy [Off Topic]

posted by mittyri  – Russia, 2019-10-28 11:13 (2080 d 16:58 ago) – Posting: # 20727
Views: 6,508
(edited on 2019-10-28 12:59)

Hi all,

Some EMA news

If the Court of Justice upholds the view that CSRs [clinical study reports] should benefit from a general presumption of confidentiality, it would change the rules of the game. Sadly, such a move could easily take us back to a situation where disclosure of clinical trial data is the exception, instead of being the norm.

See here
—
Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,695 registered users;
53 visitors (0 registered, 53 guests [including 5 identified bots]).
Forum time: 05:12 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere.    Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5